Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
deals
3
×
fda
3
×
life sciences
national blog main
san francisco blog main
akouos
boston blog main
clinical trials
national top stories
new york blog main
new york top stories
san francisco top stories
abbvie
alex gorsky
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
ashley mcevoy
astellas pharmaceuticals
astrazeneca
auris health
biogen
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cancer
cancer immunotherapy
cerovene
covid-19
crispr
decibel therapeutics
deerfield management
detroit blog main
detroit top stories
durvalumab
What
plans
3
×
deal
ipo
medicines
acquiring
acquisitions
affects
americans
announced
approved
auris
billion
bio
builds
buy
cash
ceo
collabs
company’s
covid
daniel
date
developer
developing
drug
fda
frequency
gilead
gilead’s
health
hearing
help
introduce
johnson
loss
medical
meds
millions
month
o’day
Language
unset
Current search:
fda
×
biotech
×
deals
×
plans
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B